Edition:
United States

People: Ironwood Pharmaceuticals Inc (IRWD.O)

IRWD.O on Nasdaq

10.44USD
2:21pm EDT
Change (% chg)

$0.05 (+0.48%)
Prev Close
$10.39
Open
$10.44
Day's High
$11.04
Day's Low
$10.26
Volume
1,897,853
Avg. Vol
1,366,633
52-wk High
$21.20
52-wk Low
$9.07

McCourt, Thomas 

Mr. Thomas A. McCourt is the Senior Vice President - Marketing and Sales, Chief Commercial Officer of the Company. He has served as our senior vice president of marketing and sales and chief commercial officer since joining Ironwood in 2009. Prior to joining Ironwood, Mr. McCourt led the U.S. brand team for denosumab at Amgen Inc. from April 2008 to August 2009. Prior to that, Mr. McCourt was with Novartis AG from 2001 to 2008, where he directed the launch and growth of Zelnorm for the treatment of patients with IBS-C and CIC and held a number of senior commercial roles, including vice president of strategic marketing and operations. Mr. McCourt was also part of the founding team at Astra Merck Inc., leading the development of the medical affairs and science liaison group and then serving as brand manager for Prilosec™ and NEXIUM®. Mr. McCourt serves on the board of directors of Acceleron Pharma Inc. and has a degree in pharmacy from the University of Wisconsin.

Basic Compensation

Total Annual Compensation, USD 641,000
Restricted Stock Awards, USD 440,213
Long-Term Incentive Plans, USD --
All Other, USD 1,228,130
Fiscal Year Total, USD 2,309,340

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 40,000 468,000.00
Name Fiscal Year Total

Peter Hecht

5,995,460

Gina Consylman

967,516

Mark Currie

2,624,690

Thomas McCourt

2,309,340

Halley Gilbert

1,933,570

Jon Duane

--
As Of  30 Dec 2017